Ginkgo Bioworks Holdings, Inc.DNANYSE
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank74
3Y CAGR-30.7%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
-30.7%/yr
Quarterly compound
Percentile
P74
Within normal range
vs 3Y Ago
0.3x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 21.40% |
| Q3 2025 | -37.34% |
| Q2 2025 | 26.33% |
| Q1 2025 | 14.13% |
| Q4 2024 | -87.68% |
| Q3 2024 | 75.24% |
| Q2 2024 | -25.25% |
| Q1 2024 | 0.06% |
| Q4 2023 | 37.81% |
| Q3 2023 | -55.52% |
| Q2 2023 | 14.64% |
| Q1 2023 | 8.00% |
| Q4 2022 | 64.19% |
| Q3 2022 | -1.11% |
| Q2 2022 | 4.09% |
| Q1 2022 | 59.91% |
| Q4 2021 | -6216.49% |
| Q3 2021 | 55.51% |
| Q2 2021 | -4.95% |
| Q1 2021 | -2.20% |
| Q4 2020 | -62.40% |
| Q3 2020 | -10.81% |
| Q2 2020 | -98.19% |
| Q1 2020 | 0.00% |